Though a number of biologic therapies that concentrate on kind 2 irritation can be found for remedy of persistent rhinosinusitis with nasal polyps (CRSwNP), all of them require dosing each few weeks. Gevaert et al (Lancet 2025;405(10482):911-26; https://doi.org/10.1016/S0140-6736(25)00197-7) carried out 2 randomized, placebo-controlled trials (ANCHOR-1 and ANCHOR-2) involving over 500 topics mixed to evaluate the protection and efficacy of depemokimab, an ultra-long-acting anti-IL-5 biologic, in adults with CRSwNP.
Trending Merchandise
Added to wishlistRemoved from wishlist 0
$25.00
Added to wishlistRemoved from wishlist 0
$29.71
Added to wishlistRemoved from wishlist 0
$32.99
Added to wishlistRemoved from wishlist 0
$13.99
Added to wishlistRemoved from wishlist 0
$17.99
Added to wishlistRemoved from wishlist 0
$7.85
Added to wishlistRemoved from wishlist 0
$8.83
Added to wishlistRemoved from wishlist 0
$45.40
Added to wishlistRemoved from wishlist 0
$9.99
Carlyle Cat’s Claw Capsules 1000mg | 180 Count | Uncaria Tomentosa | Non-GMO, Gluten Free Supplement
Added to wishlistRemoved from wishlist 0
$15.28